Samsung Biologics Releases Promising Fourth Quarter and End-of-Year Results
2021 was a time of growth and renewal for many companies, following the difficult first year of the COVID-19 pandemic. But COVID-19 continued in many countries and escalated in two different variants: delta and omicron. Medical companies and the biopharmaceutical manufacturing industry had to continue to create, develop, and distribute despite the challenges posed by […]
Continue Reading